WRAP North America
Part of paid clinical trials in Dothan, Alabama.
- Sponsor
- Merit Medical Systems, Inc.
- Study ID
- NCT06807099
- Status
- Recruiting
Conditions
- Venous Occlusion
- Venous Stenosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Merit WRAPSODY® Cell Impermeable Endoprosthesis (WRAPSODY CIE) — DEVICETarget Lesion treated with WRAPSODY CIE
Study Details
The goal of this observational study is to investigate the safety and efficacy of the WRAPSODY CIE in a real-world North American population. Participants treated with the WRAPSODY CIE device in accordance with the device instructions for use will be followed in accordance with standard of care up to 3-years post-procedure.
Key Dates
- Start date
- Jul 31, 2025
- Status verified
- Feb 2026
- Primary completion
- Dec 31, 2027
- Completion
- Jul 31, 2030
Study Design
- Enrollment
- 250 participants (estimated)
Primary Outcome Measure
Proportion of subjects with Target Lesion Primary Patency (TLPP) (Primary Effectiveness Endpoint) [ Time Frame: 6 months ]
Central Contacts
- Irene Coughlin+1-385-766-9133
- Vicky Brunk, RN
Locations (11)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Trinity Research Group | Dothan | Alabama | 36301 | Jason Beaver, MD (PRINCIPAL_INVESTIGATOR) |
| Sarasota Memorial Research Institute | Sarasota | Florida | 34239 | Jason Wagner, MD (PRINCIPAL_INVESTIGATOR) |
| University of Kentucky | Lexington | Kentucky | 40536 | Sayee Alagusundaramoorthy, MD (PRINCIPAL_INVESTIGATOR) |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | Adam Tanious, MD (PRINCIPAL_INVESTIGATOR) |
| Medical University of South Carolina | Orangeburg | South Carolina | 29118 | Mark London, MD (PRINCIPAL_INVESTIGATOR) |
| Spartanburg Medical System | Spartanburg | South Carolina | 29303 | Ari Kramer, MD (PRINCIPAL_INVESTIGATOR) |
| Bluff City Vascular | Memphis | Tennessee | 38104 | Omar Davis, MD (PRINCIPAL_INVESTIGATOR) |
| Texas Research Institute | Fort Worth | Texas | 76104 | Saravanan Balamuthusamy, MD (PRINCIPAL_INVESTIGATOR) |
| Humble Vascular Surgical Center | Humble | Texas | 77338 | Ruchdi Barakat, MD (PRINCIPAL_INVESTIGATOR) |
| San Antonio Kidney Disease Center | San Antonio | Texas | 78216 | Rajeev Narayan, MD (PRINCIPAL_INVESTIGATOR) |
| Sentara Vascular Specialists | Virginia Beach | Virginia | 23507 | David Dexter, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Dothan, AL
Related Studies
- The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral StudyRecruiting · W.L.Gore & Associates · Stanford, California